Diabetes Research Institute Foundation Appoints Pamela Brylski

Hialeah FL

03 December, 2020

12:02 PM

Description

Diabetes Research Institute Foundation Appoints Pamela Brylski to National Board of Directors Brylski brings extensive financial expertise to the organization dedicated to providing the funding necessary to cure diabetes MIAMI, FL – Dec. 3, 2020 – The Diabetes Research Institute Foundation (DRIF) today announced the appointment of Pamela Brylski to its National Board of Directors. Brylski joins the board with vast financial knowledge and leadership to support the organization in strategically utilizing its resources for cutting-edge research. Brylski’s experience covers a wide range of financial sectors. She is currently a senior vice president at Morgan Stanley, where she focuses on serving the wealth management needs of families and institutions. Previously, she served as a vice president in the investment management division of Goldman Sachs. Brylski also practiced as a corporate attorney with global law firms representing private equity firms, hedge funds and international corporations in a variety of domestic and international transactions. “I am confident that Pamela’s deep understanding of financial services will help drive DRIF’s efforts to allocate our generous donations most effectively,” said Sean Kramer, CEO of the Diabetes Research Institute Foundation. “The board remains committed to the highest standards, and we look forward to continuing to dedicate all resources to discovering a cure for diabetes.” Actively engaged in the community, Brylski is part of a number of philanthropic and educational organizations. She is a term member for the Council on Foreign Relations, on the alumni committee for Sponsors for Educational Opportunity (SEO), a founding member and chair of the South Florida Chapter of the Women's Association of Venture and Equity (WAVE), and a national council member of the Aspen Art Museum and the Anderson Ranch Arts Center. “I am honored to bring my skills and insight to the DRIF’s National Board to support the organization’s inspiring cause,” said Brylski. “Funding is the driving force behind the Institute’s innovative diabetes research, and I am passionate about ensuring that all investments and donations are maximized. By doing so, the organization continues to honor its donors by becoming one step closer to finding a cure to diabetes.” Brylski obtained a B.A. in Humanities Honours (Pre-Medicine) from The University of Texas at Austin and her Juris Doctorate from Georgetown University Law Center. Prior, she served as a White House intern. She resides in Coconut Grove, Miami with her husband, Cezary, and their two wonderful children, Alex and Olanna, along with their goldendoodle Coco. # # # About the Diabetes Research Institute The Diabetes Research Institute at the University of Miami Miller School of Medicine leads the world in cure-focused research. As one of the largest and most comprehensive research centers dedicated to curing diabetes, the DRI is aggressively working to develop a biological cure by restoring natural insulin production and normalizing blood sugar levels without imposing other risks. Researchers have already shown that transplanted islet cells allow patients to live without the need for insulin therapy. Some study participants have maintained insulin independence for more than 10 years. The DRI is now building upon these promising outcomes through its BioHub strategy, a multidisciplinary, three-pronged approach for addressing the major challenges that stand in the way of a cure: eliminate the need for anti-rejection drugs, reset the immune system to block autoimmunity, and develop an unlimited supply of insulin-producing cells. For more information, please visit DiabetesResearch.org or call 800-321-3437.